Clinical Trial Update: Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating paroxetine for outpatients with post-traumatic stress disorder and comorbid substance dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Medical University of South Carolina | Conditions: PTSD | Phase 4 | Status: COMPLETED